Skip to main content

Lebovits Chaim's Form 4/A amendment

Amended

Brainstorm Cell Therapeutics Inc. (BCLI) · filed Jul 31, 2024

Accession no.
0001104659-24-084343
Filed
Jul 31, 2024
Trade date
May 21-22, 2024
Filing delay
71 days
Rule 10b5-1 plan
Not checked
Original filed
May 23, 2024

This filing lists 2 non-derivative transactions. Open-market purchases total $30.5K. It was filed 71 days after the trade.

This amendment replaces 0001104659-24-064415 (filed May 23, 2024).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lebovits ChaimCIK 0001406302Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 21, 2024Common StockPPurchaseAcquired+25,000$0.58+$14,5001,124,865Direct
May 22, 2024Common StockPPurchaseAcquired+25,000$0.64+$16,0001,149,865Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

On May 23, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.

F2

Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.

Read the full filing on SEC EDGAR (opens in a new tab)